TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
盛望徽Sheng, Wang-Huei
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
vicky90180@gmail.com
發表文獻
60筆
51
Wu PY, Chen MY, Sheng WH, Hsieh SM, Chuang YC, Cheng A, Pan SC, Wu UI, Chang HY, Luo YZ, Yang SP, Zhang JY, Sun HY, Hung CC. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan. J Microbiol Immunol Infect. 2019 Aug;52(4):549-555. doi: 10.1016/j.jmii.2019.03.006. Epub 2019 Apr 11. PMID: 31036484.
52
Lee YL, Lu MC, Shao PL, Lu PL, Chen YH, Cheng SH, Ko WC, Lin CY, Wu TS, Yen MY, Wang LS, Liu CP, Lee WS, Shi ZY, Chen YS, Wang FD, Tseng SH, Lin CN, Chen YH, Sheng WH, Lee CM, Liao MH, Hsueh PR. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018. Int J Antimicrob Agents. 2019 Sep;54(3):318-328. doi: 10.1016/j.ijantimicag.2019.06.009. Epub 2019 Jun 14. PMID: 31202925.
53
Kao WF, Wang JT, Sheng WH, Chen YC. Community-acquired Legionnaires' disease at a medical center in northern Taiwan. J Microbiol Immunol Infect. 2019 Jun;52(3):465-470. doi: 10.1016/j.jmii.2017.08.018. Epub 2017 Sep 18. PMID: 28964650.
54
Chen PY, Chuang YC, Wang JT, Sheng WH, Chen YC, Chang SC. Predictors for vancomycin resistant Enterococcus faecium transforming from colonization to infection: a case control study. Antimicrob Resist Infect Control. 2019 Dec 2;8:196. doi: 10.1186/s13756-019-0647-7. PMID: 31827777; PMCID: PMC6889723.
55
Yang JH, Wu UI, Tai HM, Sheng WH. Effectiveness of an ultraviolet-C disinfection system for reduction of healthcare-associated pathogens. J Microbiol Immunol Infect. 2019 Jun;52(3):487-493. doi: 10.1016/j.jmii.2017.08.017. Epub 2017 Sep 18. PMID: 28951015.
56
Lu CW, Lee YH, Pan YH, Chang HH, Wu YC, Sheng WH, Huang KC. Tuberculosis among migrant workers in Taiwan. Global Health. 2019 Feb 28;15(1):18. doi: 10.1186/s12992-019-0461-2. PMID: 30819237; PMCID: PMC6394038.
57
Lu HF, Sheng WH, Liao SC, Chang NT, Wu PY, Yang YL, Hsiao FH. The changes and the predictors of suicide ideation and suicide attempt among HIV-positive patients at 6-12 months post diagnosis: A longitudinal study. J Adv Nurs. 2019 Mar;75(3):573-584. doi: 10.1111/jan.13883. Epub 2018 Dec 21. PMID: 30334591.
58
Wang YH, Liang JD, Sheng WH, Tien FM, Chen CY, Tien HF. Hepatitis B reactivation during treatment of tyrosine kinase inhibitors-Experience in 142 adult patients with chronic myeloid leukemia. Leuk Res. 2019 Jun;81:95-97. doi: 10.1016/j.leukres.2019.05.001. Epub 2019 May 2. PMID: 31075669.
59
Cheng A, Tsai YT, Chang SY, Sun HY, Wu UI, Sheng WH, Chen YC, Chang SC. In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02234-18. doi: 10.1128/AAC.02234-18. PMID: 30670428; PMCID: PMC6437537.
60
Ma HY, Lai CC, Chien SF, Wang JT, Sheng WH, Chen YC, Chang SC. Japanese encephalitis in a 59-year-old female: Brain image finding. J Formos Med Assoc. 2018 Aug;117(8):743-744. doi: 10.1016/j.jfma.2018.05.021. Epub 2018 Jun 6. PMID: 29884526.
